Yuichi Iwaki
2018
In 2018, Yuichi Iwaki earned a total compensation of $2.9M as President and Chief and Executive Officer at MediciNova, a 12% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $371,998 |
---|---|
Option Awards | $1,913,699 |
Salary | $551,108 |
Other | $16,500 |
Total | $2,853,305 |
Iwaki received $1.9M in option awards, accounting for 67% of the total pay in 2018.
Iwaki also received $372K in non-equity incentive plan, $551.1K in salary and $16.5K in other compensation.
Rankings
In 2018, Yuichi Iwaki's compensation ranked 4,080th out of 14,244 executives tracked by ExecPay. In other words, Iwaki earned more than 71.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,080 out of 14,244 | 71st |
Division Manufacturing | 1,503 out of 5,765 | 74th |
Major group Chemicals And Allied Products | 534 out of 2,128 | 75th |
Industry group Drugs | 446 out of 1,817 | 76th |
Industry Pharmaceutical Preparations | 344 out of 1,391 | 75th |
Source: SEC filing on April 26, 2019.
Iwaki's colleagues
We found two more compensation records of executives who worked with Yuichi Iwaki at MediciNova in 2018.